Luye Pharma Chairman Dianbo Liu On Taking “Made In China” Overseas: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Established nearly 20 years ago with $50,000, China’s Luye Pharma now has multiple products in clinical trials in the United States. In a rare interview, Luye Chairman Dianbo Liu shares his views on incremental innovation in China, and bringing traditional Chinese medicines to the world.